Alzheimer's disease & dementia

Alzheimer's treatment shows unique results

In late July there were reports in the media from a conference in Chicago about Alzheimer's disease. The focus of journalists' attention was a new study of how the progression of the disease is affected by the BAN2401 antibody, ...

Other

Juno being sued over leukemia drug study

Juno Therapeutics and its CEO, Hans E. Bishop, are being named in a lawsuit over whether the biotechnology company misled investors about the death of a patient in a key study involving its drug intended to treat leukemia.

Other

Study of promising cancer therapy halted due to deaths

A study of an experimental treatment for leukemia was abruptly halted this week following two patient deaths, raising questions about a closely-watched approach to cancer that involves reprogramming cells to seek and destroy ...

Medications

Zafgen reports second death in key drug study

Zafgen Inc. on Wednesday reported a second patient death in an ongoing study of its potential treatment for a rare genetic disorder linked to obesity.

page 1 from 3